ACRV · CIK 0001781174 · operating
Acrivon Therapeutics, Inc. (ACRV) is a pharmaceutical preparations company, listed on the Nasdaq. With a market capitalization of $53 million, Acrivon Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.52, up 0.99% today, with a 52-week range of $1.05–$5.75.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.38 | $-2.38 | +13.1% | |
| 2023 | $-2.74 | $-2.74 | +63.8% | |
| 2022 | $-7.56 | $-7.56 | — |